Loading…
Amarin Corporation plc is projected to rise to $18.28 by 2027, a +23% move from its current price of $14.88. AMRN is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $14.64 | $14.89 | $15.15 | +0.07% |
| Jul 14 | $14.55 | $14.90 | $15.26 | +0.14% |
| Jul 15 | $14.48 | $14.91 | $15.36 | +0.21% |
| Jul 16 | $14.42 | $14.92 | $15.44 | +0.27% |
| Jul 17 | $14.37 | $14.93 | $15.51 | +0.34% |
| Jul 18 | $14.33 | $14.94 | $15.58 | +0.41% |
| Jul 19 | $14.29 | $14.95 | $15.64 | +0.48% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $14.29 | $14.95 | $15.64 | +0.48% |
| Week 2 | $14.10 | $15.02 | $16.01 | +0.97% |
| Week 3 | $13.96 | $15.10 | $16.32 | +1.45% |
| Week 4 | $13.86 | $15.17 | $16.60 | +1.94% |
| Week 5 | $13.78 | $15.24 | $16.86 | +2.43% |
| Week 6 | $13.71 | $15.32 | $17.10 | +2.92% |
| Week 7 | $13.66 | $15.39 | $17.34 | +3.42% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Amarin Corporation plc is a pharmaceutical company that focuses on the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally.
It offers VASCEPA, a prescription-only omega-3 fatty acid product used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers. It collaborates with Mochida Pharmaceutical Co., Ltd.
to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
Amarin Corporation plc is the healthcare stock AMRN. The current price is $15.77, with a market capitalization of $330.68M and a market rank of 3410.
The long-range price outlook shows an upward trajectory, with the average price projected to climb to $24.26 by 2030 and to $69.15 by 2040, then to $123.62 by 2050, accompanied by ROIs of 53.8%, 338.5%, and 683.9% respectively. In the forecast, sentiment shifts from Neutral in 2026 to Bullish from 2027 onward, reflecting a constructive longer-term outlook.
A major floor 16.8% below — a decisive break under it would weaken the trend.
The nearest floor, 7.3% below — buyers have tended to step in here.
The nearest ceiling, 10.7% above — a clean break opens room to run.
A major ceiling 19.1% above — clearing it would confirm fresh momentum.
Key AMRN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AMRN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $15.27 | Sell | $15.27 | Sell |
| MA 10 | $15.70 | Sell | $15.50 | Sell |
| MA 20 | $15.70 | Sell | $15.48 | Sell |
| MA 50 | $14.96 | Sell | $15.17 | Sell |
| MA 100 | $14.87 | Buy | $15.04 | Sell |
| MA 200 | $15.44 | Sell | $14.90 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 42.08 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -126.96 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.17 | Sell |
| ROC (12) | -6.83 | Sell |
| Bollinger %B (20,2) | 0.09 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | 0.30 | Buy |
| Awesome (5,34) | 0.11 | Buy |
| Ultimate (7,14,28) | 31.36 | Neutral |
| Momentum (10) | -1.47 | Sell |
| Aroon Osc (25) | 72.00 | Buy |
| Hull MA (9) | 14.84 | Buy |
| ADX (14) | 17.89 | Neutral |
| ATR (14) | 0.25 | Info |
The near-term technical picture is bullish, with the RSI(14) at 70 indicating momentum.
The 50-day simple moving average sits at $14.58 and the 200-day simple moving average sits at $15.38, providing a short-term framework around the current price.
Support is identified at $13.80 and resistance at $15.77. The 30-day trading range spans from $13.99 to $17.78, and the stock experiences about 30% annualized volatility.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $13.50 | $14.88 | $20.51 | 0% | Neutral | |
| $14.97 | $18.28 | $23.33 | +23% | Bullish | |
| $16.89 | $21.01 | $27.54 | +41% | Bullish | |
| $17.86 | $22.55 | $30.20 | +52% | Bullish | |
| $17.65 | $22.60 | $30.81 | +52% | Bullish | |
| $20.58 | $26.67 | $36.93 | +79% | Bullish | |
| $23.57 | $30.88 | $43.37 | +108% | Bullish | |
| $26.30 | $34.83 | $49.54 | +134% | Bullish | |
| $29.71 | $39.73 | $57.20 | +167% | Bullish | |
| $30.64 | $41.37 | $60.21 | +178% | Bullish | |
| $46.07 | $64.87 | $98.95 | +336% | Bullish | |
| $79.09 | $119.45 | $195.30 | +703% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $13.50 | $14.88 | $18.08 | +0.00% |
| August 2026 | $13.55 | $15.86 | $18.97 | +6.61% |
| September 2026 | $13.47 | $15.84 | $19.09 | -0.14% |
| October 2026 | $13.46 | $15.89 | $19.28 | +0.32% |
| November 2026 | $13.86 | $16.43 | $20.04 | +3.38% |
| December 2026 | $14.07 | $16.73 | $20.51 | +1.85% |
Click any year to see its month-by-month AMRN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect AMRN to range from $13.50 to $20.51 through 2026. The $14.88 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The AMRN price prediction for 2027 points to an average of $18.28 (low $14.97, high $23.33) — a potential gain of +23% on today's $14.88. Momentum favours further upside here.
In 2028, AMRN is projected to trade between $16.89 and $27.54, averaging $21.01 — a potential gain of +41% from today's $14.88. That is up +15% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Amarin Corporation plc's 2029 outlook centres on $22.55, within a $17.86 to $30.20 range. That is up +7% on the projected 2028 average. That marks a +52% change versus current levels. Momentum favours further upside here.
By 2030, AMRN could reach as high as $30.81, with a base case around $22.60 and support toward $17.65 — roughly +52% from $14.88. Buyers look set to stay in control over this stretch.
Expect AMRN to range from $20.58 to $36.93 through 2031. The $26.67 average target implies a +79% move from current prices. That is up +18% on the projected 2030 average. Momentum favours further upside here.
The AMRN price prediction for 2032 points to an average of $30.88 (low $23.57, high $43.37) — a potential gain of +108% on today's $14.88. Buyers look set to stay in control over this stretch.
In 2033, AMRN is projected to trade between $26.30 and $49.54, averaging $34.83 — a potential gain of +134% from today's $14.88. That is up +13% on the projected 2032 average. Momentum favours further upside here.
Amarin Corporation plc's 2034 outlook centres on $39.73, within a $29.71 to $57.20 range. That is up +14% on the projected 2033 average. That marks a +167% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, AMRN could reach as high as $60.21, with a base case around $41.37 and support toward $30.64 — roughly +178% from $14.88. Momentum favours further upside here.
Expect AMRN to range from $46.07 to $98.95 through 2040. The $64.87 average target implies a +336% move from current prices. That is up +57% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The AMRN price prediction for 2050 points to an average of $119.45 (low $79.09, high $195.30) — a potential gain of +703% on today's $14.88. Momentum favours further upside here.
Investing $1,000 in AMRN today (≈ 67.204301 AMRN) could be worth
$8,027.35
+$7,027.35 (+703%) by 2050 · US Dollar
Based on the average projected AMRN price of $119.45 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AMRNwould be worth at today's price.
$1,000 invested in AMRN on Jul 10, 2025 (≈ 57.736722 AMRN) would be worth
$859.12
-$140.88 (-14.1%) today · 0.86× · US Dollar
Based on a AMRN entry price of $17.32 vs. today's $14.88.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $16.37 | $908.98 | -9.1% |
| 1 month ago | $14.76 | $1,008.13 | +0.8% |
| 3 months ago | $14.48 | $1,027.62 | +2.8% |
| 6 months ago | $15.56 | $956.3 | -4.4% |
| 1 year ago | $17.32 | $859.12 | -14.1% |
| All time (5.0y) ago | $85.8 | $173.43 | -82.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AMRN forecast.
Our base-case forecast reaches $30.00 around 2032.
Implied market cap at $30.00: $629.07M
The multi-year forecast shows bullish sentiment building in the later years, with stronger upside potential as time progresses.
By 2030, the average price is projected at $24.26, with a min of $18.93 and a max of $33.10, and an estimated ROI of 53.8%.
By 2040, the average price is forecast at $69.15, with a max of $105.54 and a min of $49.09, and an estimated ROI of 338.5%.
By 2050, the average price is forecast at $123.62, with a max of $202.21 and a min of $81.82, and an estimated ROI of 683.9%. These are estimates and not guarantees, and actual results may vary.
Tap a question to reveal the answer.
The forecast shows an avg price of $24.26, a min of $18.93, a max of $33.10, with a ROI of 53.8% and bullish sentiment.
Forecasts indicate bullish sentiment from 2027 onward with high potential ROIs, including 683.9% by 2050, but these are estimates and not guarantees.
Yes. The forecast max values include $52.61 in 2033 and $61.24 in 2034, indicating a path above $50 in the mid-2030s.
Current price is $15.77 and market cap is $330.68M.
The 30-day range is from $13.99 to $17.78.
Amarin Corporation plc Community Discussion
0Share your Amarin Corporation plc price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.